Volume | Year
News and Announcements
A brief introduction of School of Basic Medical Sciences Peking University
Dating back to 1954, SBMS, known as the School of Basic Medical Sciences Peking University, offered the first preclinical medicine major in China and witnessed history of the country’s modern medical development. The School had the only eight-year program nationwide that was authorized by the Ministry of Education (MOE), which enabled students to obtain undergraduate training and a Ph.D degree.
A great many outstanding pioneers and educators of basic medical sciences have gathered here. In recent years, as teaching reform focusing on PBL (Problem-Based Learning) method proceeds, fruitful achievements have been made. The School has published 22 national-planning textbooks, and offered hundreds of courses for undergraduate and postgraduate students, among which there are seven national-level open courses of excellence, nine national-level courses of excellence, and ten municipal-level courses of excellence. The School has obtained two second prizes for the national-level teaching achievement, one first prize for municipal-level teaching achievement, coupled with seven teachers winning the Beijing Distinguished Teacher award and two national-level teaching teams.
After more than 60 years of development, SBMS is noted for its rigorous and innovative scholarly tradition, and has made a remarkable contribution to the nation’s medical education and research. The School has ranked in the first place for three times out of the four education evaluation projects run by MOE after 2000, and preclinical medicine major has been selected into the list of “double first-rate” initiative in 2017. The School has now become a leading national institution for teaching and research in the field of basic medical sciences.
the School of Basic Medical Sciences encourages innovative research and has accomplished multiple achievements that has won National Science and Technology awards. Representative cases include research on neurochemical principle of acupuncture analgesia, fertilization and embryo transfer in vitro, differentiation and development of T cell, molecular mechanism of estrogen-related tumor, molecular biology of hepatitis E virus (HEV), molecular pathology and immunological mechanism of emerging infectious diseases, molecular regulatory mechanism and quantitative measurements of cellular aging, etc.
During the past five years, the school has approved more than a hundred scientific projects and published nearly 400 research papers every year, including more than 200 SCI papers with members of the school as first authors or corresponding authors. So far, the School of Basic Medical Sciences has won nine provincial- and ministerial-level Science and Technology Awards and one State Natural Science Award; obtained 36 national invention patents and 5 international invention patents. The school has also independently developed a category-I new drug “novel tumor-specific imaging agent” which was approved by China Food and Drug Administration (CFDA) for clinical trials and has realized technology transfer and industrialization by now.